Dr. Nallan C Chari, PH.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 108 Forest Ave, Altamonte Springs, FL 32701 Phone: 407-339-8998 Fax: 407-339-2242 |
Dr. Mohamed Samy Elwany, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 600 E Altamonte Drive, Suite 1700, Altamonte Springs, FL 32701 Phone: 407-331-8883 |
Carol Maniaci Johnson, AU.D., CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 711 E Altamonte Dr, Suite 200, Altamonte Springs, FL 32701 Phone: 407-303-5466 Fax: 407-303-5467 |
News Archive
Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair based on hyaluronic acid (HA) technology, today announced that it has received Health Canada approval for MONOVISC™, its single injection viscosupplement approved for the treatment of osteoarthritis of the knee. Anika expects to launch MONOVISC this month through its long-term ORTHOVISC® distribution partner in Canada, Rivex Pharma Inc., the specialty drug distribution division of Aurora, Ontario-based Helix BioPharma Corp. (TSX: HBP). MONOVISC has been broadly available in the European Union since the second quarter of 2008.
Celiac disease is more common among Massachusetts children born in the spring or summer, and this higher incidence could be related to the intersection of key seasonal and environmental factors, according to researchers at the Massachusetts General Hospital for Children.
A team of researchers at the University of California, San Diego and Stanford University has developed a way to simulate blood flow on the computer to optimize surgical designs. It is the basis of a new tool that may help surgeons plan for a life-saving operation called the "Fontan" surgery, which is performed on babies born with severe congenital heart defects.
Researchers at the University of Wisconsin-Madison School of Medicine and Public Health have identified a molecular mechanism that allows two powerful signaling pathways to interact and begin a process leading to colorectal tumors.
A new study shows significant differences in brain development in high-risk infants who develop autism starting as early as age 6 months. The findings published in the American Journal of Psychiatry reveal that this abnormal brain development may be detected before the appearance of autism symptoms in an infant's first year of life. Autism is typically diagnosed around the age of 2 or 3.
› Verified 1 days ago